Issue 1/2019
Content (4 Articles)
Adalimumab
Psoriasis (J Wu, Section Editor)
Update on Risankizumab for Psoriasis
Jennifer C. Bares, Mark G. Lebwohl
Etanercept
Psoriasis (J Wu, Section Editor)
Tildrakizumab for Moderate-to-Severe Chronic Plaque Psoriasis: a Review of the Literature
Kory P. Schrom, Avi Bitterman, Neil J. Korman
Methotrexate
Psoriasis (J Wu, Section Editor)
Nanotechnology for Psoriasis Therapy
Emily C. Murphy, Samuel W. Schaffter, Adam J. Friedman
Etanercept
Invited Commentary
Biosimilars for Psoriasis—Experience from Europe
Arnon D. Cohen, Tiago Torres, Wolf-Henning Boehncke, Menno de Rie, Denis Jullien, Luigi Naldi, Caitriona Ryan, Robert Strohal, Lone Skov, Peter van de Kerkhof, Joelle M. van der Walt, Jashin J. Wu, Claus Zachariae, Lluis Puig, Helen Young